RARA and acute myeloid leukemia: In AML, MLL PTDs, FLT3 ITDs, and PML/RARA fusions are important for determining prognosis, and we demonstrated Barnacle’s potential for large-scale studies by successfully predicting these events in two RNA-seq datasets.